Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

Last updated: 16.7.2025
Grant

This program, part of Horizon Europe, focuses on enhancing pandemic preparedness by deepening the understanding of viral proteins and their immunogenicity. It aims to accelerate the development of innovative vaccine candidates against emerging and re-emerging viral infections, thereby strengthening global health security and Europe's role in therapeutic research and development.

Who is Funded for Pandemic Preparedness and Response

This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its core objectives. The funding targets scientific and clinical communities globally, with a specific focus on developing crucial knowledge and interventions for pandemic preparedness.

What is Funded in Viral Immunogenicity Research

This section details the specific types of projects and activities eligible for funding, focusing on critical research areas, the developmental stages of supported projects, and information on eligible costs. The program prioritizes research and innovation in vaccine development and related fields for high-threat viruses.

Type and Scope of Funding for Health Innovations

This section outlines the financial parameters of the program, including the type of financial support provided, the maximum funding available per project, and information on project duration. The program primarily offers grants to support crucial research and innovation actions.

Conditions and Requirements for Applicants

This section covers the essential conditions and requirements for applicants and beneficiaries, including detailed rules for application submission, consortium formation, and adherence to various regulations. Adherence to these conditions is crucial for successful participation.

Application and Selection Process

This section outlines the application and selection processes for the funding program, from submission procedures to how applications are evaluated and awards are granted. It provides a clear guide for prospective applicants.

This section details the foundational legal and official documents that govern the funding program, ensuring transparency and compliance. It identifies the primary authorization and other key regulations that shape its operation.

Similar Programs

#Pandemic preparedness#Immunogenicity#Viral proteins#Vaccine development#Infectious diseases#Horizon Europe#Health research#Epidemic response#Clinical studies#Pre-clinical testing#Global health security#EU funding#Health innovation#Research grants#Emerging viruses#Disease burden#Medical countermeasures#Public health#Biotechnology#Scientific community

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

8,000,000 €

Allocated Budget

Allocated Budget:

50,000,000 EUR

Deadline

Deadline:

13.04.2023

Open Until

Open Until:

Ongoing

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union and globally, including United States of America.

Sectors

Sectors:

Healthcare, Research and Development, Pharmaceutical Industry

Beneficiaries

Beneficiaries:

Scientific and clinical communities

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

European Commission

Additional Partners:

European Health Emergency and Response Authority (HERA)

0 x 0
XS